Scholars Central

EditorialPublished Feb 2013

Imaging Biomarkers in Drug Development

Authors: Sheela Agarwal, Janet C. Miller, Sanjay Saini

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Imaging Biomarkers in Drug Development The price tag of drug development has steadily increased over the years with it now costing an average of $1.3 billion and ten years to bring a new drug to market. These staggering numbers play a significant role in the rising price of drugs. For example, the anti-cancer drug, bevacizumab costs about $50,000 for one year’s treatment. This contributes to the unsustainable rise in healthcare expense and leads to increasing pressure to reduce the costs of drug development.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Biomarkers in Drug Development.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiomarkers in Drug Development
  • SubjectPathology & Lab Medicine
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Sheela Agarwal”
  • BylineArticles whose byline prints “Janet C. Miller”
  • BylineArticles whose byline prints “Sanjay Saini”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels